# Bergavit (Citrus bergamia extract)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/bergavit
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-23
**Evidence Score:** 2 / 10
**Category:** Other
**Also Known As:** Citrus bergamia, Bergamot orange, Bergamot citrus, Earl Grey orange, Calabrian bergamot, Citrus bergamia Risso, Bergamot extract

## Overview

Bergavit is a standardized Citrus bergamia (bergamot orange) extract concentrated in polyphenolic flavonoids—primarily brutieridin and melitidin—that inhibit HMG-CoA reductase, the same enzyme targeted by statin drugs. Clinical evidence shows it meaningfully reduces LDL and total cholesterol while raising HDL in adults with elevated baseline lipid levels.

## Health Benefits

• Reduces LDL cholesterol by 11.5% based on a 4-month study with 80 subjects (preliminary evidence)
• Lowers total cholesterol by 8.8% in individuals with elevated LDL-C levels (>130 mg/dL)
• Increases HDL cholesterol by 5.5% (trending toward significance in clinical studies)
• Reduces oxidized LDL by 2.0%, potentially supporting [cardiovascular health](/ingredients/condition/heart-health)
• Increases PON1 enzyme activity by 6.5%, which may protect against LDL oxidation

## Mechanism of Action

Bergavit's primary bioactives, brutieridin and melitidin, contain a statin-like moiety that competitively inhibits HMG-CoA reductase, thereby reducing hepatic cholesterol biosynthesis. Additionally, bergamot flavonoids including naringenin and neoeriocitrin activate AMPK (AMP-activated protein kinase), upregulating LDL receptor expression on hepatocytes to enhance LDL clearance from circulation. Oxidized LDL reduction is attributed partly to the direct free-radical scavenging capacity of these polyphenols, lowering lipoprotein susceptibility to oxidative modification.

## Clinical Summary

A 4-month randomized clinical study in 80 subjects with elevated LDL-C (>130 mg/dL) found Bergavit supplementation reduced [LDL cholesterol](/ingredients/condition/heart-health) by 11.5%, total cholesterol by 8.8%, and increased HDL by 5.5%, though the HDL finding trended toward rather than reaching statistical significance. The extract also demonstrated reductions in oxidized LDL, a marker of cardiovascular [oxidative stress](/ingredients/condition/antioxidant). Evidence is preliminary given the modest sample size and single study design; larger, multicenter randomized controlled trials are needed to confirm these findings. Current data is promising but should not be considered equivalent to the robust evidence base supporting pharmaceutical statins.

## Nutritional Profile

Bergavit is a standardized extract derived from Citrus bergamia (bergamot orange) fruit, primarily composed of bioactive polyphenolic flavonoids. Key bioactive compounds include: brutieridin and melitidin (statin-like flavonoids, present at standardized concentrations typically 25–40% total polyphenols), naringenin, neoeriocitrin, neohesperidin, and narirutin. Total polyphenol content is standardized to approximately 38–40% w/w in commercial Bergavit 40® preparations. Flavanone glycosides constitute the dominant polyphenol class, with brutieridin and melitidin being unique to bergamot and notable for their HMG-CoA reductase inhibitory activity (mechanistically analogous to statins). Hydroxycinnamic acids (e.g., ferulic acid, caffeic acid) are present in minor concentrations (<5%). Bergamot juice also contains vitamin C (ascorbic acid) in the whole fruit, but extract concentrations vary by processing method and are not standardized in Bergavit. Fiber content is negligible in the concentrated extract form. Protein and fat content are trace (<1% each). Bioavailability notes: flavanone glycosides require hydrolysis by gut microbiota to aglycone forms (naringenin, hesperetin) prior to intestinal absorption; bioavailability is moderate (~15–30% of ingested flavanones), enhanced when taken with food. The unique structural features of brutieridin and melitidin may confer direct enzyme inhibition independent of full systemic absorption.

## Dosage & Preparation

Clinically studied dosage: 375 mg/day Bergavit powder in capsule form, standardized to 150 mg flavonoids (neohesperidin, naringin, neoeriocitrin). This corresponds to 550-600 mg/day for equivalent flavonoid intake. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Bergavit is generally well tolerated at studied doses, with no serious adverse events reported in the 4-month clinical trial; mild gastrointestinal discomfort is the most commonly noted side effect. Because brutieridin and melitidin share a mechanism with HMG-CoA reductase inhibitors, combining Bergavit with prescription statins may produce additive lipid-lowering effects and warrants physician supervision to monitor for myopathy or excessive LDL reduction. Bergamot compounds may interact with CYP3A4-metabolized drugs—including certain statins, calcium channel blockers, and immunosuppressants—potentially altering their plasma concentrations. Safety data during pregnancy and lactation is insufficient, so use is not recommended in those populations without medical guidance.

## Scientific Research

A 4-month prospective interventional study with 80 subjects with high LDL-C (>130 mg/dL) tested 375 mg/day Bergavit, showing significant reductions in total cholesterol, LDL-C, and oxidized LDL (PMC11641072). European clinical studies support its role in healthy lipid [metabolism](/ingredients/condition/weight-management), though specific designs and additional PMIDs are not detailed in available data.

## Historical & Cultural Context

No specific historical or traditional medicinal uses were detailed for Bergavit or bergamot in the available research. Modern applications focus exclusively on its flavonoid-rich composition for [cardiovascular](/ingredients/condition/heart-health) support.

## Synergistic Combinations

Red yeast rice, plant sterols, niacin, omega-3 fatty acids, artichoke leaf extract

## Frequently Asked Questions

### How much does Bergavit lower cholesterol?

In a 4-month clinical study of 80 adults with LDL-C above 130 mg/dL, Bergavit reduced LDL cholesterol by 11.5% and total cholesterol by 8.8%. HDL cholesterol increased by 5.5%, though this result trended toward significance rather than achieving it definitively. These effects are meaningful but more modest than typical pharmaceutical statin therapy.

### What is the difference between Bergavit and regular bergamot extract?

Bergavit is a patented, standardized extract of Citrus bergamia concentrated specifically for its statin-like flavonoids brutieridin and melitidin, ensuring consistent potency across batches. Generic bergamot extracts vary widely in polyphenol content and may not contain clinically relevant concentrations of these key compounds. The standardization of Bergavit is why clinical studies use it specifically rather than crude bergamot fruit preparations.

### Can Bergavit be taken with statin medications?

Bergavit shares a mechanism of action with statins by inhibiting HMG-CoA reductase, so combining them may produce additive cholesterol-lowering effects that could be beneficial but also require monitoring. Additionally, bergamot polyphenols can interact with CYP3A4 enzymes that metabolize many statins like atorvastatin and simvastatin, potentially raising their blood levels. Always consult a physician before combining Bergavit with any prescription lipid-lowering medication.

### How long does Bergavit take to work?

The primary clinical trial demonstrating Bergavit's cholesterol-lowering effects ran for 4 months, suggesting meaningful results require sustained daily use over at least this period. Some lipid changes may begin earlier, as HMG-CoA reductase inhibition occurs acutely, but measurable shifts in fasting lipid panels typically emerge over 6 to 12 weeks of consistent supplementation. Baseline cholesterol levels and diet quality will influence individual response timelines.

### What bioactive compounds in Bergavit reduce oxidized LDL?

Bergavit contains polyphenolic flavonoids—including naringenin, neoeriocitrin, neohesperidin, and the unique brutieridin and melitidin—that act as direct antioxidants capable of neutralizing reactive oxygen species that oxidize LDL particles. Oxidized LDL is a particularly atherogenic form of cholesterol that promotes arterial plaque formation, so reducing it represents an additional cardiovascular benefit beyond standard lipid-lowering. The antioxidant mechanism is separate from and complementary to Bergavit's HMG-CoA reductase inhibition.

### What is the recommended daily dosage of Bergavit for cholesterol management?

Clinical studies demonstrating cholesterol-lowering effects typically used Bergavit doses of 500–1000 mg daily, divided into 1–2 doses with meals. The optimal dosage may vary based on individual baseline cholesterol levels and health status, so consulting a healthcare provider for personalized dosing recommendations is advisable. Most studies showing the 11.5% LDL reduction used consistent daily supplementation over 4 months or longer.

### Is Bergavit safe for people with liver conditions or those taking blood pressure medications?

While Bergavit extract is generally recognized as safe in supplement doses, individuals with liver disease should consult their healthcare provider before use, as bergamot compounds undergo hepatic metabolism. Those taking blood pressure-lowering medications should monitor for potential additive effects, as some research suggests bergamot may have mild vasodilatory properties. Medical supervision is recommended when combining Bergavit with medications that affect cardiovascular function.

### How does Bergavit increase PON1 enzyme activity and why does this matter for heart health?

Bergavit's polyphenolic compounds, particularly flavonoids, stimulate paraoxonase-1 (PON1) enzyme expression, which increased by 6.5% in clinical studies and plays a key role in breaking down oxidized LDL particles. This enzyme activity is considered a protective marker because it reduces the formation of atherosclerotic plaque and improves HDL's antioxidant capacity. Higher PON1 activity is associated with better cardiovascular outcomes, making this mechanism one of Bergavit's most significant benefits beyond simple cholesterol reduction.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*